Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Pan, Suo"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Junbin Huang, Guanhua Hu, Pan Suo, Lu Bai, Yifei Cheng, Yu Wang, XiaoHui Zhang, KaiYan Liu, YuQian Sun, LanPing Xu, Jun Kong, ChenHua Yan, Xiaojun Huang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundAMKL without DS is a rare but aggressive hematological malignant disease in children, and it is associated with inferior outcomes. Several researchers have regarded pediatric AMKL without DS as high-risk or at least intermediate-risk AML an
Externí odkaz:
https://doaj.org/article/c9ccd54fdc7f41d6807e88d272330523
Autor:
Zhou, Hua-Qiang, Zhang, Ya-Xiong, Chen, Gang, Yu, Qi-Tao, Zhang, Hua, Wu, Guo-Wu, Wu, Di, Lin, Ying-Cheng, Zhu, Jun-Fei, Chen, Jian-Hua, Hu, Xiao-Hua, Lan, Bin, Zhou, Ze-Qiang, Lin, Hai-Feng, Wang, Zi-Bing, Lei, Xiao-Lin, Pan, Suo-Ming, Chen, Li-Ming, Zhang, Jian, Kong, Tian-Dong
Publikováno v:
Signal Transduction & Targeted Therapy; 8/13/2024, Vol. 9 Issue 1, p1-12, 12p
Autor:
Guanhua Hu, Yifei Cheng, Yingxi Zuo, Yingjun Chang, Pan Suo, Yueping Jia, Aidong Lu, Yu Wang, Shunchang Jiao, Longji Zhang, Yuqian Sun, Chenhua Yan, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, Leping Zhang, Xiaojun Huang
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Measurable residual disease (MRD) positivity before haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is an independent prognostic factor in determining outcomes in patients with B-cell acute lymphoblastic leukemia (ALL). In this st
Externí odkaz:
https://doaj.org/article/a2af3c1c69eb468d95c1fee20d05f89d
Autor:
Guan-hua Hu, Yi-fei Cheng, Ai-dong Lu, Yu Wang, Ying-xi Zuo, Chen-hua Yan, Jun Wu, Yu-qian Sun, Pan Suo, Yu-hong Chen, Huan Chen, Yue-ping Jia, Kai-yan Liu, Wei Han, Lan-ping Xu, Le-ping Zhang, Xiao-jun Huang
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Pediatric acute myeloid leukemia (AML) with t(8;21) (q22;q22) is classified as a low-risk group. However, relapse is still the main factor affecting survival. We aimed to investigate the effect of allogeneic hematopoietic stem cel
Externí odkaz:
https://doaj.org/article/b4dc714a28e140b080eb6251de92151d
Autor:
Guan-hua Hu, Yi-fei Cheng, Ying-xi Zuo, Ying-jun Chang, Pan Suo, Jun Wu, Yue-ping Jia, Ai-dong Lu, Ying-chun Li, Yu Wang, Shun-chang Jiao, Long-ji Zhang, Xiang-yu Zhao, Chen-hua Yan, Lan-ping Xu, Xiao-hui Zhang, Kai-yan Liu, Le-ping Zhang, Xiao-jun Huang
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
BackgroundThe presence of minimal residual disease (MRD) is an independent risk factor for poor prognosis in patients with acute lymphoblastic leukemia (ALL). Moreover, the role of chimeric antigen receptor T-cell (CAR-T) therapy in patients with MRD
Externí odkaz:
https://doaj.org/article/af3c56d9f626408f844f712ad374a2b1
Autor:
Yao Li, Guan-Hua Hu, Lan-Ping Xu, Xiao-Hui, Zhang Kai-Yan Liu, Pan Suo, Yu Wang, Yi-Fei Cheng, Xiao-Jun Huang
Publikováno v:
Journal of Pediatric Hematology/Oncology; Jul2024, Vol. 46 Issue 5, p241-247, 7p
Autor:
Ke Wang, Meng Lv, Ying-Jun Chang, Xiang-Yu Zhao, Xiao-Su Zhao, Yuan-Yuan Zhang, Yu-Qian Sun, Zhi-Dong Wang, Pan Suo, Yang Zhou, Dan Liu, Shu-Zhen Zhai, Yan Hong, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-16 (2019)
Abstract Introduction Myeloid-derived suppressor cells (MDSCs) are proposed to control graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the definition of human MDSCs has not yet reached cons
Externí odkaz:
https://doaj.org/article/8445d808756242e78d2519232c065132
Autor:
Yu-Qian Sun, Yu Wang, Feng-Rong Wang, Chen-Hua Yan, Yi-Fei Cheng, Yu-Hong Chen, Yuan-Yuan Zhang, Ting-Ting Han, Wei Han, Pan Suo, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Graft failure (GF) is a fatal complication of allogeneic stem cell transplantation, especially after haploidentical transplantation. The mortality of GF is nearly 100% without an effective salvage method. A second transplantation is usually necessary
Externí odkaz:
https://doaj.org/article/ce515adc41e54652a204e554ec04785b
Autor:
Feng Zhang, Le-ping Zhang, Guan-hua Hu, Lan-ping Xu, Pan Suo, Yu Wang, Lu Bai, Kai-yan Liu, Xiao-hui Zhang, Xiao-Jun Huang, Yi-fei Cheng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5059d22541e3f50ec5653410fd89d76f
https://doi.org/10.22541/au.168499809.98235528/v1
https://doi.org/10.22541/au.168499809.98235528/v1